Table 3 Predicted antigenic B-cell epitopes of ZIKV’ NS5 protein*.

From: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins

No.

Start position

End position

Peptide

Peptide length

1

13

21

RAVVSCAEA

9

2

67

91

ASSLINGVVRLLSKPWDVVTGVTGI

25

3

101

107

QQRVFKE

7

4

140

147

RPRVCTKE

8

5

181

186

FWALVD

6

6

194

203

RGECQSCVYN

10

7

231

241

ARFLEFEALGF

11

8

262

270

LQRLGYVLE

9

9

312

322

RALALAIIKYT

11

10

324

333

QNKVVKVLRP

10

11

353

361

GQVVTYALN

9

12

364

371

TNLVVQLI

8

13

413

421

GDDCVVKPI

9

14

426

431

AHALRF

6

15

457

470

VPFCSHHFNKLHLK

14

16

473

484

RSIVVPCRHQDE

12

17

488

494

RARVSPG

7

18

501

509

ETACLAKSY

9

19

512

520

MWQLLYFHR

9

20

528

539

NAICSSVPVDWV

12

21

560

566

MLVVWNR

7

22

597

604

WCGSLIGH

8

  1. *22 antigenic sites were identified from the ZIKV NS5 protein. Residues (in bold) were also predicted as CTL epitopes.